Patents by Inventor Kueichen Chiang

Kueichen Chiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody having immunosuppressive activity or antigen binding fragment thereof
    Patent number: 9701739
    Abstract: The present invention relates to a monoclonal antibody having excellent immunosuppressive activity or an antigen binding fragment thereof. More specifically, the present invention relates to a monoclonal antibody or an antigen binding fragment thereof, which binds to a peptide consisting an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO: 1) or a conjugate of the peptide and a pharmaceutically acceptable carrier, the monoclonal antibody or an antigen binding fragment thereof having a higher binding affinity for core histone than for histone H1.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: July 11, 2017
    Assignee: Josai University Corporation
    Inventors: Shuji Sato, Takeshi Goto, Shigeru Goto, Toshiaki Nakano, Naoya Ohmori, Kueichen Chiang, Yayoi Shimada, Kenji Mori, Takamitsu Miyagi
  • THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE
    Publication number: 20170096478
    Abstract: The present invention relates to a therapeutic agent for inflammation in which histone is involved, the agent comprising a monoclonal antibody or an antigen binding fragment thereof which binds to a peptide consisting of an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO:1) or a conjugate of the peptide and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 13, 2016
    Publication date: April 6, 2017
    Inventors: Shuji SATO, Takeshi GOTO, Naoya OHMORI, Kueichen CHIANG, Yayoi SHIMADA, Masafumi INOMATA, Toru KUSANO, Takahiro HIRATSUKA, Takayuki NOGUCHI, Satoshi HAGIWARA
  • THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE
    Publication number: 20150079090
    Abstract: The present invention relates to a therapeutic agent for inflammation in which histone is involved, the agent comprising a monoclonal antibody or an antigen binding fragment thereof which binds to a peptide consisting of an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO:1) or a conjugate of the peptide and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: February 22, 2013
    Publication date: March 19, 2015
    Inventors: Shuji Sato, Takeshi Goto, Naoya Ohmori, Kueichen Chiang, Yayoi Shimada, Masafumi Inomata, Toru Kusano, Takahiro Hiratsuka, Takayuki Noguchi, Satoshi Hagiwara
  • MONOCLONAL ANTIBODY HAVING IMMUNOSUPPRESSIVE ACTIVITY OR ANTIGEN BINDING FRAGMENT THEREOF
    Publication number: 20140010815
    Abstract: The present invention relates to a monoclonal antibody having excellent immunosuppressive activity or an antigen binding fragment thereof. More specifically, the present invention relates to a monoclonal antibody or an antigen binding fragment thereof, which binds to a peptide consisting an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO: 1) or a conjugate of the peptide and a pharmaceutically acceptable carrier, the monoclonal antibody or an antigen binding fragment thereof having a higher binding affinity for core histone than for histone H1.
    Type: Application
    Filed: August 19, 2011
    Publication date: January 9, 2014
    Applicant: JOSAI UNIVERSITY CORPORATION
    Inventors: Shuji Sato, Takeshi Goto, Shigeru Goto, Toshiaki Nakano, Naoya Ohmori, Kueichen Chiang, Yayoi Shimada, Kenji Mori, Takamitsu Miyagi
  • IMMUNE ADJUVANT COMPRISING ATP
    Publication number: 20120128706
    Abstract: This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant. More specifically, the present invention relates to an immunoadjuvant comprising ATP or its pharmaceutically acceptable salt, its solvate, or its derivative having a physiological function as an active ingredient, and a vaccine composition comprising the immunoadjuvant.
    Type: Application
    Filed: December 12, 2011
    Publication date: May 24, 2012
    Inventors: Shuji Sato, Takeshi Goto, Naoya Ohmori, Kueichen Chiang, Yayoi Shimada
  • Immune adjuvant comprising ubiquinone
    Publication number: 20090252751
    Abstract: This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant.
    Type: Application
    Filed: June 26, 2008
    Publication date: October 8, 2009
    Inventors: Shuji Sato, Takeshi Goto, Naoya Ohmori, Kueichen Chiang, Yayoi Shimada
  • Immune adjuvant comprising ATP
    Publication number: 20090081247
    Abstract: This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant. More specifically, the present invention relates to an immunoadjuvant comprising ATP or its pharmaceutically acceptable salt, its solvate, or its derivative having a physiological function as an active ingredient, and a vaccine composition comprising the immunoadjuvant.
    Type: Application
    Filed: June 25, 2008
    Publication date: March 26, 2009
    Inventors: Shuji Sato, Takeshi Goto, Naoya Ohmori, Kueichen Chiang, Yayoi Shimada